Terms: = Germ cell tumor AND MEN1, ENSG00000133895, 4221 AND Staging
22 results:
1. Visual analysis of lung neuroendocrine tumors based on CiteSpace knowledge graph.
Guo M; Hu S; Xiao Y; Cao Z; Huang Z; Liu Y; An X; Zhang G; Zheng X
Front Endocrinol (Lausanne); 2023; 14():1214404. PubMed ID: 37745715
[TBL] [Abstract] [Full Text] [Related]
2. Pancreatic imaging in men1-comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting.
Kostiainen I; Majala S; Schildt J; Parviainen H; Kauhanen S; Seppänen H; Miettinen PJ; Matikainen N; Ryhänen EM; Schalin-Jäntti C
Eur J Endocrinol; 2023 May; 188(5):421-429. PubMed ID: 36943311
[TBL] [Abstract] [Full Text] [Related]
3. Gastric neuroendocrine neoplasms: a primer for radiologists.
Roseland ME; Francis IR; Shampain KL; Stein EB; Wasnik AP; Millet JD
Abdom Radiol (NY); 2022 Dec; 47(12):3993-4004. PubMed ID: 35411433
[TBL] [Abstract] [Full Text] [Related]
4. [Comparison of clinical features between sporadic pancreatic neuroendocrine tumors and those associated with multiple endocrine neoplasia type 1].
Gu DY; Fu Q; Xue BY; Kan JB; Bai JA; Tang QY
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1014-1019. PubMed ID: 35399021
[No Abstract] [Full Text] [Related]
5. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas.
Mete O; Asa SL; Gill AJ; Kimura N; de Krijger RR; Tischler A
Endocr Pathol; 2022 Mar; 33(1):90-114. PubMed ID: 35285002
[TBL] [Abstract] [Full Text] [Related]
6. Value of Somatostatin Receptor PET/CT in Patients With men1 at Various Stages of Their Disease.
Mennetrey C; Le Bras M; Bando-Delaunay A; Al-Mansour L; Haissaguerre M; Batisse-Lignier M; Ouvrard E; Ansquer C; Walter T; de Mestier L; Kelly A; Tlili G; Giraud S; North MO; Odou MF; Goichot B; Cuny T; Loundou A; Romanet P; Imperiale A; Taïeb D
J Clin Endocrinol Metab; 2022 Apr; 107(5):e2056-e2064. PubMed ID: 34940846
[TBL] [Abstract] [Full Text] [Related]
7. The Impact of
Cuthbertson DJ; Barriuso J; Lamarca A; Manoharan P; Westwood T; Jaffa M; Fenwick SW; Nuttall C; Lalloo F; Prachalias A; Pizanias M; Wieshmann H; McNamara MG; Hubner R; Srirajaskanthan R; Vivian G; Ramage J; Weickert MO; Pritchard DM; Vinjamuri S; Valle J; Yip VS
Front Endocrinol (Lausanne); 2021; 12():654975. PubMed ID: 34163434
[TBL] [Abstract] [Full Text] [Related]
8. Pancreatic Gastrinoma, Gastrointestinal Stromal tumor (GIST), Pheochromocytoma, and Hürthle cell Neoplasm in a Patient with Neurofibromatosis Type 1: A Case Report and Literature Review.
Arif AA; Kim PTW; Melck A; Churg A; Schwartz Z; Stuart HC
Am J Case Rep; 2021 Jan; 22():e927761. PubMed ID: 33452231
[TBL] [Abstract] [Full Text] [Related]
9. Incidental finding of MEN-1 syndrome during staging and follow-up of breast carcinoma.
Maria BC; Quadros AC; Alves N; Coutinho J
BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33370954
[TBL] [Abstract] [Full Text] [Related]
10. Molecular profile of pancreatic neuroendocrine neoplasms (PanNENs): Opportunities for personalized therapies.
Arakelyan J; Zohrabyan D; Philip PA
Cancer; 2021 Feb; 127(3):345-353. PubMed ID: 33270905
[TBL] [Abstract] [Full Text] [Related]
11. Duodenal, ampullary, and pancreatic neuroendocrine tumors: Oncologic outcomes are driven by tumor biology and tissue of origin.
Schmocker RK; Wright MJ; Ding D; Javed AA; Cameron JL; Lafaro K; Burns WR; He J; Wolfgang CL; Burkhart RA
J Surg Oncol; 2021 Feb; 123(2):416-424. PubMed ID: 33125737
[TBL] [Abstract] [Full Text] [Related]
12. Pancreatic grade 3 neuroendocrine tumors behave similarly to neuroendocrine carcinomas following resection: a multi-center, international appraisal of the WHO 2010 and WHO 2017 staging schema for pancreatic neuroendocrine lesions.
Worth PJ; Leal J; Ding Q; Trickey A; Dua MM; Chatzizacharias N; Soonawalla Z; Athanasopoulos P; Toumpanakis C; Hansen P; Parks RW; Connor S; Parker K; Koea J; Srinavasa S; Ielpo B; Vicente Lopez E; Lawrence B; Visser BC;
HPB (Oxford); 2020 Sep; 22(9):1359-1367. PubMed ID: 32081540
[TBL] [Abstract] [Full Text] [Related]
13. PANCREATIC NEUROENDOCRINE tumorS: SURGICAL RESECTION.
Belotto M; Crouzillard BDNS; Araujo KO; Peixoto RD
Arq Bras Cir Dig; 2019 Feb; 32(1):e1428. PubMed ID: 30758476
[TBL] [Abstract] [Full Text] [Related]
14. Loss of Chromatin-Remodeling Proteins and/or CDKN2A Associates With Metastasis of Pancreatic Neuroendocrine tumors and Reduced Patient Survival Times.
Roy S; LaFramboise WA; Liu TC; Cao D; Luvison A; Miller C; Lyons MA; O'Sullivan RJ; Zureikat AH; Hogg ME; Tsung A; Lee KK; Bahary N; Brand RE; Chennat JS; Fasanella KE; McGrath K; Nikiforova MN; Papachristou GI; Slivka A; Zeh HJ; Singhi AD
Gastroenterology; 2018 Jun; 154(8):2060-2063.e8. PubMed ID: 29486199
[TBL] [Abstract] [Full Text] [Related]
15. The role of 68-Ga-DOTATOC CT-PET in surgical tactic for gastric neuroendocrine tumors treatment: our experience: a case report.
Cavallaro A; Zanghì A; Cavallaro M; Lo Menzo E; Di Carlo I; Di Vita M; Cardì F; Piccolo G; Di Mattia P; Cappellani A
Int J Surg; 2014; 12 Suppl 1():S225-31. PubMed ID: 24862665
[TBL] [Abstract] [Full Text] [Related]
16. Neuroendocrine tumors of the pancreas: current concepts and controversies.
Reid MD; Balci S; Saka B; Adsay NV
Endocr Pathol; 2014 Mar; 25(1):65-79. PubMed ID: 24430597
[TBL] [Abstract] [Full Text] [Related]
17. Hormone profiling, WHO 2010 grading, and AJCC/UICC staging in pancreatic neuroendocrine tumor behavior.
Morin E; Cheng S; Mete O; Serra S; Araujo PB; Temple S; Cleary S; Gallinger S; Greig PD; McGilvray I; Wei A; Asa SL; Ezzat S
Cancer Med; 2013 Oct; 2(5):701-11. PubMed ID: 24403235
[TBL] [Abstract] [Full Text] [Related]
18. Role of endoscopy in the management of gastroenteropancreatic neuroendocrine tumours.
De Angelis C; Pellicano R; Rizzetto M; Repici A
Minerva Gastroenterol Dietol; 2011 Jun; 57(2):129-37. PubMed ID: 21587152
[TBL] [Abstract] [Full Text] [Related]
19. Tumours of familial origin in the head and neck.
Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
[TBL] [Abstract] [Full Text] [Related]
20. Unusual functioning endocrine tumors.
Raut CP; Lee JE
Curr Treat Options Oncol; 2004 Aug; 5(4):327-34. PubMed ID: 15233909
[TBL] [Abstract] [Full Text] [Related]
[Next]
